NASDAQ · NTHI
NeOnc Technologies Holdings, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for NTHI: Nov 13, 2026
NeOnc Technologies Holdings, Inc. Common Stock is estimated to report earnings on 11/13/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.41. The reported EPS for the same quarter last year was $-0.45.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.41 | $-0.34 | $-0.47 | 2 |
| Dec 2026 | $-0.47 | $-0.47 | $-0.47 | 2 |
| Mar 2027 | $-0.43 | $-0.43 | $-0.43 | 1 |
| Jun 2027 | $-0.43 | $-0.43 | $-0.43 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Fintel- RTTNews · Sep 29, 2:48 PM EDTBiotech Stocks On The Move – SLXN, SMMT, IOVA, NTHI(RTTNews) – The following biotech stocks recorded notable moves on September 29, 2026, following key developments including positive preclinical data, a strategic investment, higher revenue guidance and encouraging clinical data.
- RTTNews · Sep 28, 12:57 PM EDTNeOnc Plans FDA Discussions On NEO212 Clinical Development And Potential Approval Pathway(RTTNews) – NeOnc Technologies Holdings, Inc. (NTHI) announced that it is scheduled to meet with the U.S. Food and Drug Administration (FDA) on November 17, 2026, for an in-person End-of-Phase 1 Type B meeting concerning NEO212.
- RTTNews · Sep 9, 12:26 PM EDTNeOnc Technologies Prices $15M Registered Direct Offering With Institutional Investors(RTTNews) – NeOnc Technologies Holdings, Inc. (NTHI) announced that it has entered into definitive securities purchase agreements with new and existing healthcare-focused institutional investors for a registered direct offering expected to generate approximately $15 million in gr
- RTTNews · Aug 21, 10:17 AM EDTWeekly Buzz: RARE, REGN Secure FDA Nod, BMRN Stikes Deal; HUMA, EYPT Face Trial Setbacks(RTTNews) – This week's global biopharma roundup captured a mix of regulatory approvals, strategic partnerships, acquisitions, and merger activity, alongside clinical trial breakthroughs and halts. Positive readouts across autoimmune myositis, glioma, and melanoma were offset by
- RTTNews · Aug 18, 10:58 AM EDTNeOnc's Phase 2a Data Shifts Nasdaq Narrative; Stock Up(RTTNews) – NeOnc Technologies Holdings (NTHI) has reported Phase 2a results for its NEO100 in recurrent IDH1-mutant high-grade glioma, marking a pivotal moment for the company's Nasdaq listing.
- RTTNews · Aug 15, 2:59 AM EDTWeekly Buzz: LNTH, CBLL Win FDA Nod; AURA Cuts Jobs; TDY Buys VREX; CGEM, DFTX Meet Trial Goals(RTTNews) – This week's global biopharma sector roundup captured a mix of regulatory wins, restructuring activities, deals that expanded company pipelines, and clinical trial readouts.
- RTTNews · Jul 15, 9:55 AM EDTNeOnc Receives FDA Written Feedback On NEO212 Development And Capsule-to-Tablet Transition(RTTNews) – NeOnc Technologies Holdings, Inc. (NTHI) announced that it has received written feedback from the U.S FDA regarding the chemistry, manufacturing and controls (CMC) program for NEO212.
- RTTNews · Jul 15, 9:33 AM EDTNeOnc Technologies Receives Written Feedback From FDA Regarding NEO212 Development(RTTNews) – Wednesday, NeOnc Technologies Holdings, Inc. (NTHI) announced that the company has received written feedback from the U.S. Food and Drug Administration providing detailed manufacturing and formulation requirements for continued late-stage development of NEO212, a pote
- RTTNews · Jun 16, 11:02 PM EDTTop Biotech Gainers: CRVO On Watch, SLP Scooped Up, LNAI Back In Compliance, NTHI Advances NEO212(RTTNews) – Tuesday's top gainers include CervoMed, with key clinical trial catalysts ahead; Conexeu, which strengthened its leadership with board expansion; NeOnc, advancing its lead drug candidate into Phase 2 for aggressive brain tumours; and Simulations Plus, which is set to
- Fintel · May 19, 8:04 PM EDTAlliance Global Partners Initiates Coverage of NeOnc Technologies Holdings (NTHI) with Buy RecommendationFintel reports that on May 19, 2026, Alliance Global Partners initiated coverage of NeOnc Technologies Holdings (NasdaqGM:NTHI) with a Buy recommendation. Analyst Price Forecast Suggests 178.18% Upside
- Fintel · May 18, 8:04 PM EDTMaxim Group Initiates Coverage of NeOnc Technologies Holdings (NTHI) with Buy RecommendationFintel reports that on May 18, 2026, Maxim Group initiated coverage of NeOnc Technologies Holdings (NasdaqGM:NTHI) with a Buy recommendation. Analyst Price Forecast Suggests 185.45% Upside
- Fintel · Apr 24, 8:04 PM EDTBTIG Initiates Coverage of NeOnc Technologies Holdings (NTHI) with Buy RecommendationFintel reports that on April 24, 2026, BTIG initiated coverage of NeOnc Technologies Holdings (NasdaqGM:NTHI) with a Buy recommendation. What is the Fund Sentiment?
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for NeOnc Technologies Holdings, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.